Cyclerion Therapeutics (CYCN) Receivables (2020 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Receivables of $1.0 million in Q4 2025, up 900.0% quarter-over-quarter from $100000.0 in Q3 2025, and up 79.86% on a YoY basis from $556000.0 in Q4 2024.
Cyclerion Therapeutics (CYCN) Receivables (2020 - 2025) Analysis & Trends
Cyclerion Therapeutics' Receivables history runs 6 years deep, the most recent figure standing at $1.0 million for Q4 2025.
- In Q4 2025, Receivables rose 79.86% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 79.86% YoY), while the FY2025 annual figure was $1.0 million, up 79.86% from the prior year.
- Receivables was $1.0 million for Q4 2025 at Cyclerion Therapeutics, up from $100000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $1.0 million in Q4 2025 to a low of $44000.0 in Q3 2024.
- Historically, Receivables has averaged $302846.2 across 5 years, with a median of $227000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Receivables plunged 57.71% in 2023, then surged 127.27% in 2025.
- A 5-year view of Receivables shows it stood at $100000.0 in 2021, then retreated by 4.0% to $96000.0 in 2022, then changed by 0.0% to $96000.0 in 2023, then soared by 479.17% to $556000.0 in 2024, then jumped by 79.86% to $1.0 million in 2025.
- The last three Receivables figures came in at $1.0 million (Q4 2025), $100000.0 (Q3 2025), and $525000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 525,000.00 |
| Mar 31, 2025 | 581,000.00 |
| Dec 31, 2024 | 556,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Mar 31, 2023 | 96,000.00 |
| Dec 31, 2022 | 96,000.00 |
| Sep 30, 2022 | 227,000.00 |
| Jun 30, 2022 | 227,000.00 |
| Mar 31, 2022 | 227,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Dec 31, 2020 | 127,000.00 |